SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Caresia-Aróztegui AP (1), Delgado-Bolton RC (2), Alvarez-Ruiz S (3), Del Puig Cózar-Santiago M (4), Orcajo-Rincon J (5), de Arcocha-Torres M (6), García-Velloso MJ (7); en nombre del Grupo de Trabajo de Oncología de la Sociedad Española de Medicina Nuclear e Imagen Molecular.

    (1) Servicio de Medicina Nuclear, UDIAT, Hospital de Sabadell, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, España.
    (2) Departamento de Diagnóstico por Imagen y Medicina Nuclear, Hospital San Pedro-Centro de Investigación Biomédica de La Rioja (CIBIR), Logroño, España.
    (3) Servicio de Medicina Nuclear, Hospital Universitario Miguel Servet, Zaragoza, España.
    (4) Servicio de Medicina Nuclear, ERESA, Hospital General Universitario de Valencia, Valencia, España.
    (5) Servicio de Medicina Nuclear, Hospital General Universitario Gregorio Marañón, Madrid, España.
    (6) Unidad de Radiofarmacia, Hospital Universitario Marqués de Valdecilla, Santander, España.
    (7) Servicio de Medicina Nuclear, Clínica Universidad de Navarra, Pamplona, España.

    Revista Española de Medicina Nuclear e Imagen Molecular 12 NOVEMBER 2018

  • 3D printing in neurosurgery: a specific model for patients with craniosynostosis

    Jiménez Ormabera B (1), Díez Valle R (2), Zaratiegui Fernández J (3), Llorente Ortega M (4), Unamuno Iñurritegui X (4), Tejada Solís S (5). (1) Facultad de Medicina, Pamplona, España.
    (2) Departamento de Neurocirugía, Clínica Universidad de Navarra, Pamplona, España.
    (3) Laboratorio de Arquitectura - Fabricación Digital, Escuela Técnica Superior de Arquitectura de la Universidad de Navarra, Pamplona, España.
    (4) Laboratorio de Ingeniería Médica, Facultad de Medicina de la Universidad de Navarra, Pamplona, España.
    (5) Departamento de Neurocirugía, Clínica Universidad de Navarra, Pamplona, España

    Neurocirugía 27 JULY 2017

  • 11C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions

    Lapa C (1), Garcia-Velloso MJ (2), Lückerath K 1, Samnick S 1, Schreder M (3), Otero PR (2), Schmid JS 1, Herrmann K 1,4, Knop S 3, Buck AK (1), Einsele H (3), San-Miguel J (2), Kortüm KM (3). (1) University Hospital Würzburg, Department of Nuclear Medicine, Würzburg, Germany.
    (2) Clinica Universidad de Navarra, Center of Applied Medical Research, Navarra Institute for Health Research (CIMA). IDISNA, Pamplona, Spain.
    (3) University Hospital Würzburg, Department of Hematology and Oncology, Würzburg, Germany.
    (4) University Hospital Essen, Department of Nuclear Medicine, Essen, Germany.

    Theranostics 24 JULY 2017

  • 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome

    García Vicente AM (1), Delgado-Bolton RC (2), Amo-Salas M (3), López-Fidalgo J (4), Caresia Aróztegui AP (5), García Garzón JR (6), Orcajo Rincón J (7), García Velloso MJ (8), de Arcocha Torres M (9), Alvárez Ruíz S (10); Oncology Task Force of Spanish Society of Nuclear Medicine and Molecular Imaging. (1) Nuclear Medicine Department, University General Hospital, C/ Obispo Rafael Torija s/n, 13005, Ciudad Real, Spain. angarvice@yahoo.es.
    (2) Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR), University of La Rioja, Logroño, Spain.
    (3) Department of Mathematics, University of Castilla-La Mancha, Ciudad Real, Spain.
    (4) Universidad de Navarra, ICS, Unidad de Estadística, Campus Universitario, 31080, Pamplona, Spain.
    5 Nuclear Medicine Department, Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain.
    (6) Unitat PET/TC CETIR-ERESA, Barcelona, Spain.
    (7) Nuclear Medicine Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
    (8) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (9) Nuclear Medicine Department, Hospital Universitario Marques de Valdecilla, Santander, Spain.
    (10) Nuclear Medicine Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.

    European Journal of Nuclear Medicine and Molecular Imaging 27 MAY 2017

  • 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Cardoso F (1), van't Veer LJ (1), Bogaerts J (1), Slaets L (1), Viale G (1), Delaloge S (1), Pierga JY (1), Brain E (1), Causeret S (1), DeLorenzi M (1), Glas AM (1), Golfinopoulos V (1), Goulioti T (1), Knox S (1), Matos E (1), Meulemans B (1), Neijenhuis PA (1), Nitz U (1), Passalacqua R (1), Ravdin P (1), Rubio IT (1), Saghatchian M (1), Smilde TJ (1), Sotiriou C (1), Stork L (1), Straehle C (1), Thomas G (1), Thompson AM (1), van der Hoeven JM (1), Vuylsteke P(1), Bernards R (1), Tryfonidis K (1), Rutgers E (1), Piccart M (1); MINDACT Investigators.

    (1) From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

    The New England Journal Medicine 25 AUGUST 2016

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra